This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
The early-onset familial AD (EOFAD) linked to presenilin 1 (PS1) mutations show a heterogeneous phenotype that is illustrated mainly by the coexistence of dementia with spastic paraparesis, described in a few kindreds.1-3⇓⇓ The altered processing of amyloid precursor protein, favoring the production of the longer amyloid β-peptide form ending at residue 42 (Aβ42), is the major pathogenic effect of PS1 mutations.4 The relationship between clinical phenotype and Aβ42 production is unclear. We report a kindred bearing a novel PS1 mutation that showed an extremely wide clinical spectrum among the three affected members.
Case report and methods.
A 45-year-old woman (I-1) showed progressive paraparesis followed after 5 years by dementia. She died at age 57, and autopsy was not performed. Her daughter (II-2) presented at 48 years with delusional thinking followed by progressive impairment of all cognitive functions. Neurologic examination at 55 years did not reveal loss of strength or pyramidal signs at the limbs. Her brother (II-3) became symptomatic at the …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Topics Discussed
Alert Me
Recommended articles
Biochemical markers in persons with preclinical familial Alzheimer disease
Alpha-1-antitrypsin deficiency alleles are not associated with cervical artery dissections
A Novel Mutation in the Sterol 27-hydroxylase Gene of a Pakistani Family with Autosomal Recessive Cerebrotendinous Xanthomatosis
Disease duration in autosomal dominant familial Alzheimer disease